MedPath

Physiological-based Cord Clamping in Congenital Diaphragmatic Hernia

Not Applicable
Recruiting
Conditions
Hernia; Diaphragm Defect, Congenital
Pulmonary Hypertension
Hernias, Diaphragmatic, Congenital
Interventions
Procedure: Physiological-based cord clamping
Registration Number
NCT04373902
Lead Sponsor
Erasmus Medical Center
Brief Summary

Pulmonary hypertension is a major determinant of postnatal survival in infants with a congenital diaphragmatic hernia (CDH). The current care during the perinatal stabilisation period in infants born with this rare birth defect might contribute to the development of pulmonary hypertension after birth - in particular umbilical cord clamping before lung aeration. An ovine model of diaphragmatic hernia demonstrated that cord clamping after lung aeration, called physiological-based cord clamping (PBCC), avoided the initial high pressures in the lung vasculature while maintaining adequate blood flow, thereby avoiding vascular remodelling and aggravation of pulmonary hypertension. The investigators aim to investigate if the implementation of PBCC in the perinatal stabilisation period of infants born with a CDH could reduce the incidence of pulmonary hypertension in the first 24 hours after birth.

The investigators will perform a multicentre, randomised controlled trial in infants with an isolated CDH. Before birth, infants will be randomised to either PBCC or immediate cord clamping, stratified by treatment centre and severity of pulmonary hypoplasia on antenatal ultrasound. For performing PBCC a purpose-designed resuscitation module (the Concord Birth Trolley) will be used.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
140
Inclusion Criteria
  • Left-sided CDH
  • Isolated CDH: no associated structural or genetic abnormalities that are diagnosed before birth
  • Gestational age at delivery ≥35.0 weeks
  • Parental written informed consent
Exclusion Criteria
  • Right-sided or bilateral CDH
  • Gestational age at delivery <35.0 weeks
  • Maternal contraindications: anterior placenta praevia, placental abruption
  • High urgency caesarean section, with intended interval to delivery <15 min
  • Cases that have been treated during pregnancy with experimental drug therapy aiming to decrease the occurrence of pulmonary hypertension
  • Twin pregnancies in which the infant diagnosed with a CDH is born first
  • Multiple birth >2 (triplets or higher order)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Physiological-based cord clampingPhysiological-based cord clampingIn PBCC, the Concord will be placed next to the bed of the mother and all equipment will be checked before the second stage of labour has started. The infant will be placed on the platform of the Concord immediately after birth, avoiding any traction or pressure on the cord and avoiding heat loss by radiation heating. The umbilical cord will not be clamped until the infant is considered respiratory stable, which is defined as the presence of a heart rate \>100 bpm and preductal oxygen saturation \>85%, while using an fraction of inspired oxygen (FiO2) of \<0.5. The minimum and maximum times of cord clamping are three and ten minutes after birth, respectively. Oxytocin administration will be postponed until after cord clamping if there are no obstetric concerns. At any time, the attending neonatologist and obstetrician can decide that PBCC should not be performed or be interrupted. In that case, the infant can be placed on the standard resuscitation table for (further) stabilisation.
Primary Outcome Measures
NameTimeMethod
Number of participants with pulmonary hypertension diagnosed in the first 24 hours after birth.First 24 hours after birth

Pulmonary hypertension is present if at least 2 of the following 4 criteria are present or if the infant requires extracorporeal membrane oxygenation (ECMO) in the first 24 hours after birth:

1. Right ventricular systolic pressure (RVSP) ≥2/3 systemic systolic pressure\*

2. Right ventricle (RV) dilatation/septal displacement or RV dysfunction +/- left ventricle (LV) dysfunction\*

3. Pre-post ductal SpO2 difference \>10% for at least 15 consecutive minutes

4. Oxygenation Index \>20\*\* \*as found on first ultrasound in first 24 hours after birth; \*\*highest value measured in first 24 hours after birth

The following echocardiographic parameters will be collected to objectify these criteria:

* RV size

* Pulmonary artery acceleration time (PAAT), right ventricular ejection time (RVET), PAAT:RVET ratio

* Intraventricular septum configuration

* LV systolic eccentricity index

* Mean airway pressure

* PaO2

* FiO2

* Preductal+postductal SpO2

Secondary Outcome Measures
NameTimeMethod
Neonatal: presence of 3 or more criteria for pulmonary hypertension or extracorporeal membrane oxygenation within 24 hours after birthThe first 24 hours after delivery

Number of patients with 3 or more criteria or ECMO

Neonatal: number of patients requiring ECMO therapyFrom admission to the ICU until the date of death or the date of discharge home, whichever came first

Number of patients requiring ECMO therapy

Neonatal: number of days of duration of mechanical ventilationFrom admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year

Number of days of duration of mechanical ventilation

Neonatal: duration of admission to the tertiary care hospitalFrom admission to the ICU until the date of discharge to another ward or home, whichever came first

Number of days of admission to the tertiary care hospital

Neonatal: number of days of duration of supplemental oxygen needFrom admission to the ICU until the date of discharge to another ward or home, whichever came first,through study completion an average of one year

Number of days of duration of supplemental oxygen need

Maternal: number of patients with postpartum haemorrhageThe first 24 hours after delivery

Postpartum haemorrhage is defined as estimated blood loss \>1000 mL

Neonatal: mortality before discharge from the tertiary care hospitalFrom birth till discharge from the tertiary care hospital, through study completion an average of one year

Number of patients that died before discharge

Trial Locations

Locations (9)

Monash University

🇦🇺

Melbourne, Australia

Medical University Graz

🇦🇹

Graz, Austria

University Hospitals leuven

🇧🇪

Leuven, Belgium

Universitätskrankenhaus Bonn

🇩🇪

Bonn, Germany

Universitätsklinik Mannheim

🇩🇪

Mannheim, Germany

Ospedale Pediatrico Bambino Gesu

🇮🇹

Rome, Italy

Radboudumc University Medical Center

🇳🇱

Nijmegen, Netherlands

Erasmus MC University Medical Center - Sophia Children's Hospital

🇳🇱

Rotterdam, Netherlands

Karolinska University Hospital

🇸🇪

Stockholm, Sweden

© Copyright 2025. All Rights Reserved by MedPath